OrganiGram Holdings Inc (NASDAQ:OGI) joined the Phase 2 pilot program of Shoppers (Medical Cannabis by Shoppers) to ensure all the cannabis products delivered to the communities are genuine and comes with high quality and potency. Tracking facilities for medical cannabis products are supported by TruTrace Technologies Inc (OTCMKTS:TTTSF).
The program for medicinal-use cannabis products
All the participating cannabis products in this program are genetically fingerprinted and tracked using blockchain technology throughout the supply chain. It helps the customers get real-time information about each cannabis product’s composition and make an informed decision for their medical needs. As part of this program, OrganiGram will supply cannabis products to Shoppers, which is entrusted with the responsibility of providing tracking information with the help of TruTrace.
The consistent quality of cannabis products
Validated and standardized test procedures are used to test cannabis products and ensure their medicinal use efficacy and consistency. Product information such as potency and strain composition is provided to help customers, and healthcare providers make an informed and confident decision to choose the right product for their treatment.
Greg Engel, CEO of OrganiGram, said the company is committed to providing genuine cannabis products to the communities for medical use. It takes utmost care from the development stage to deliver innovative products in satisfying the patients’ needs and healthcare providers.
OrganiGram knows that consistency of cannabis products is vital for patients. To fulfill this commitment, the company entered a pact with Shoppers, which tracks the information say from raw material selection to finished product.
Strain Secure system
The Strain Secure System offered by TruTrace gathers plant testing data and conducts a genome verification of each plant’s batch. Such vital information is then stored in the database supported by blockchain technology for strain validation and IP (Intellectual Property) protection. Therefore, it facilitates the tracking of information collected from plants like chemical makeup and molecular details.
The jurisdictions across the world began the legalization and adoption of cannabis for medical treatment. It resulted in the mushrooming of new growers and breeders together with new strains. Significant changes in various strains’ chemical properties pose a challenge for healthcare providers and patients in selecting the right medical use cannabis products.
Shoppers signed an agreement with UHN (University Health Network in Toronto) using the technology of TruTrace to introduce MCRWE (Medical Cannabis Real World Evidence). The company expects at least 2,000 patients over a 24-week duration in this observational study. It is useful in the absence of DIN for cannabis products to quantify metabolomics and genetics and ensure potency.